Optibrium, a developer of software for drug discovery, has announced a collaboration to provide StarDrop users with easy access to EnamineStore, a database of their commercially available screening compounds and chemical building blocks
Enamine, a chemical research organisation and TBD Biodiscovery, a GMP manufacturer of fine chemicals have announced a collaboration agreement to manage the transition of chemical synthesis of novel intermediates from laboratory to bulk scale under GMP standards
Enamine, a chemical research organisation and producer of the world’s largest collections of novel building blocks (150,000) and screening compound libraries (2,400,000), and BioSolveIT, premium provider of medicinal chemistry software, have announced the launch of the ‘REAL Space Navigator’
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
